Literature DB >> 2857750

Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.

G T Makoul, D R Robinson, A K Bhalla, L H Glimcher.   

Abstract

To minimize complicating interactions inherent in heterogeneous cell populations, we used a panel of cloned murine autoreactive (E8.A1) and antigen-specific (HEL.C10, HEL.B14) T cell hybridomas to examine the effect of prostaglandin E2 (PGE2) on T cell activation. These T cells secrete interleukin 2 (IL 2) when co-cultured with a cloned population of I region-matched stimulator cells (TA3), or with mitogenic signals in the absence of TA3 stimulator cells. Physiologic concentrations of PGE2 inhibited the induction of IL 2 secretion by the T cell hybridomas tested, when they were activated either by TA3 cells or by mitogenic signals. IL 2 production was inhibited in a dose-dependent manner by concentrations of PGE2 between 10(-7) and 10(-11) M, with 50% inhibition occurring at 10(-10) M. Pretreatment of the T hybridoma cells with 10(-7) M PGE2 for 1 hr before culture also resulted in marked inhibition of IL 2 secretion. Similar pretreatment of the TA3 cells did not affect their ability to activate the T cell hybridomas. PGE2 at 10(-8) M induced a 30-fold increase in cAMP levels within 25 min of addition to culture of the E8.A1 T cell hybridoma, but caused no significant elevation of cAMP levels in TA3 cells. The direct addition of dibutyryl cAMP (dcAMP) to cultures of E8.A1 cells resulted in marked inhibition of IL 2 secretion when stimulated by TA3 or by mitogenic signals, with an average of 80% inhibition occurring at 10(-4) M dcAMP. PGE2 and dcAMP also inhibited the growth of E8.A1 cells. Initially, cell growth was virtually halted, but began to recover between 24 and 48 hr after the addition of either PGE2 or dcAMP. Neither PGE2 nor dcAMP inhibited the division of TA3 cells. High affinity binding sites for PGE2 were detected in the E8.A1 T cell hybridomas with an apparent Kd of 7.6 X 10(-10) M, which is consistent with the functional data. No specific binding was detected in the TA3 stimulator cells. These findings suggest that the immunosuppressive effects of PGE2 are localized to the T cell, are receptor regulated, and may be mediated by the associated increase of cAMP levels in the T cell hybridomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857750

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.

Authors:  S Takaya; O Bronsther; K Abu-Elmagd; H Ramos; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1993-06       Impact factor: 1.066

2.  Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP.

Authors:  H T Poteat; P Kadison; K McGuire; L Park; R E Park; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.

Authors:  K Ishihara; S Ono; Y Takahama; F Hirayama; H Hirano; K Itoh; K Dobashi; S Murakami; Y Katoh; M Yamaguchi
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

4.  Effect of misoprostol on concentrations of prostaglandins in synovial fluid.

Authors:  A Doube; J Davies; L Notarianni; K Holgate; G C Fenn
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.

Authors:  J G Valenzuela; Y Belkaid; M K Garfield; S Mendez; S Kamhawi; E D Rowton; D L Sacks; J M Ribeiro
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

6.  Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements.

Authors:  L B Ivashkiv; L H Glimcher
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

7.  Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response.

Authors:  Saba Alzabin; Saiju Pyarajan; Herman Yee; Friedemann Kiefer; Akira Suzuki; Steven Burakoff; Sansana Sawasdikosol
Journal:  Cancer Immunol Immunother       Date:  2009-09-29       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.